Kalofonos Isabel (CIK 1975163) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-01). Recent activity: Sell CRNX (1,669 shares), Sell CRNX (34,000 shares), Buy CRNX (34,000 shares), Buy CRNX (2,500 shares), Sell CRNX (2,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Commercial Officer | Sell | 1,669 | $141,865 |
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Commercial Officer | Sell | 34,000 | $2.9M |
| 2026-02-25 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Commercial Officer | Buy | 34,000 | $0 |
| 2026-01-07 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Commercial Officer | Buy | 2,500 | $101,475 |
| 2026-01-07 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Commercial Officer | Sell | 2,500 | $137,500 |
来源：SEC Form 4 申报文件 · 截至 2026-09-01